Thu Oct 7 BST - Fri Oct 8 BST (11 days ago)
In your timezone (EDT): Thu Oct 7 3:30am - Fri Oct 8 1:40pm
Due to the pandemic we have decided that for the second time Sachs Basel events will be held in a digital format, thus allowing us to support our community and past attendees. We will provide both the usual stimulating programme and the networking opportunities through the online meeting system. We are constantly reviewing the situation and circumstances permitting, plan to announce in June that part of the Sachs Autumn Life Sciences Week programme will be delivered physically in Basel on the 7th and 8th of October. This would include live speeches and presentations as part of the 21st BEF with in person meetings and the event reception for both events. We will update all those who registered and when registering please indicate by ticking the appropriate box whether you would be interested in attending in person. Updates on any possible hybrid format will be posted on this website.
Back for its 21st Annual Edition, this global bio-pharma industry event will address through its programme the main challenges for 2021 in investment, partnering and alliance management and prospects for 2022. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.
Nigel Sheail, Global Head of M&A and BD&L, Novartis International AG
Stephan Emmerth, Director Business Development & Operations, BaseLaunch
Agnieszka Blum, General Director of the Immunology, Ardigen S.A.
Alison Haggerty, Partner, Latham & Watkins LLP
Allan Marchington, Managing Director & Head of Life Sciences of Intermediate Capital Group Plc
Aram Mangasarian, CEO, NOXXON Pharma NV
Avaleigh Milne , Oncology Basel Site Head, Pharma Partnering, F. Hoffmann-La Roche Ltd.
Bharat Ramachandran, Director, Head of Business Development, Immunology & Global Health, EMD Serono, Inc., an affiliate of Merck in the U.S. & Canada
Bibhash Mukhopadhyay, Independent
Corinne Venot, Executive Director, Business Development, BeiGene Ltd.
Daniel Teper, CEO, Cytovia Therapeutics Inc.
Daniela Begolo, Senior Associate, INKEF Capital BV
Deborah Rathjen, Executive Chair & CEO, Bioasis Technologies, Inc.
Edyta Jaworska, Management Board Member, Selvita S.A.
Eric Halioua, President & CEO, PDC*line Pharma SA
Erik Manting, CEO, Immunicum AB
Esteban Pombo-Villar, CTO, TargImmune Therapeutics AG
Fintan Walton, Founder & CEO, PharmaVentures Ltd.
Frauke Hein, Co-Founder & CBO, Adrenomed AG
Gabriel Cavazos, Managing Director in Investment Banking , SVB Leerink
Gil Bar-Nahum, Managing Director, EMEA Head of Biotechnology, Jeeries International Ltd.
Guillaume Vignon, SVP, Business Development, BeiGene Ltd.
Hans Herklots, Managing Director, LifeSci Advisors
Hubert Birner, Managing Partner, TVM Life Science Management GmbH
Isabel Ferreira, Chief Business Officer, Versameb AG
Jean-Marc Bourez, EIT Health Services & Investment Co-Managing Director & French Hub Managing Director, EIT Health e.V.
Jesús Martin-Garcia, CEO, GeNeuro SA
Jie Liu, Managing Director, Torreya Partners LLP
John Alam, President & CEO, EIP Pharma, Inc.
Justyna Czyszek, Investor Support Department Vice-President, Krakowski Park Technologiczny sp. z o.o.
Kazimierz Murzyn, CEO, Klaster LifeScience Krakow
Khatereh Ahmadi, Executive Director, Oncology Search & Evaluation Lead for Europe, MSD
Kristen Albright, CEO, Prokarium Ltd.
Lubor Gaal, Managing Director, Locust Walk
Lynn Durham, Founder & CEO, STALICLA SA
Mai-Britt Zocca, Founder & CEO, IO Biotech ApS
Marianne Uteng, Principal, Novartis Venture Fund
Marietta Wu, Managing Director, Quan Capital
Markus Hosang, General Partner, BioMedPartners AG
Martin Welschof, CEO, BioInvent International AB
Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck
Montserrat Cano, CEO, Nanoligent SL
Michael Altorfer, CEO, Swiss Biotech Association
Michael Huebner, Director Early Innovation Partnering, Johnson & Johnson Innovation LLC
Michael Maguire, CEO, Avectas Ltd.
Michael Rice, VP, Head of Advanced Therapeutics, Cello Health BioConsulting
Miguel Forte, CEO, Bone Therapeutics SA
Mike Romanos, Co-Founder & CEO, Microbiotica Ltd.
Mirjam Heeb, Investment Advisor, HBM Partners AG
Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, AbbVie, Inc.
Mythili Koneru, Chief Medical Officer, Marker Therapeutics, Inc.
Natalie Mount, CEO, Adaptate Biotherapeutics Ltd.
Nathalie ter Wengel, European Lead, Worldwide Business Development, Pfizer, Inc.
Nicholas Franco, EVP & Chief Business Development Officer, Allschwil Site Head, Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson
Olivier Reinhard, Head Of Business Development, Emerging Markets EPD of Abbott
Paul Hermant, Partner, Bird & Bird LLP
Paul Rennert, President & CSO, Aleta Biotherapeutics
Phil L'Huillier, CEO, CatalYm GmbH
Rainer Strohmenger, Managing Partner, Wellington Partners
Rao Movva, Novartis Distinguished Scientist & Independent Pharma & Biotech Advisor
Reagan Jarvis, CEO, Anocca AB
Richard Ward, Senior Director, Search & Evaluation, AstraZeneca
Sam Fazeli, Head of Research, Senior Pharmaceuticals Analyst, Bloomberg Intelligence
Sandra Ferri, Head of Life Sciences Investments, European Investment Fund
Sarah Holland, CBO, VectivBio AG
Sascha Bucher, Co-Founding Partner, Forty51 Ventures
Simone Botti, Junior Partner, INKEF Capital BV
Søren Bregenholt, CEO, Alligator Bioscience AB
Søren Møller, Managing Partner, Novo Holdings A/S
Stefan Luzi, Partner, Gilde Healthcare Partners B.V
Stéphane Boissel, President & CEO, SparingVision
Stephanie Léouzon, Partner & Head of Europe, Torreya Partners LLP
Susan Hill, CEO, Mestag Therapeutics Limited
Susanne Wilke, President & CEO, Cognoptix, Inc.
Theodora Harold, CEO, Crescendo Biologics Ltd.
Thibaut Roulon, Senior Investment Director, Bpifrance
Thijs Cohen Tervaert, Junior Partner, INKEF Capital BV
Tim Haines, Chairman & Managing Partner of Abingworth LLP
Tim Luker, VP Venture Science, Corp BD, Eli Lilly and Company
Ulrich Wendt, Head of Immunology Business Development, Sanofi
Vanela Bushi, Director, Strategy & Transactions Europe Lead, Syneos Health, LLC
Xin Liu, Partner, Eight Roads Ventures
Yochi Slonim, Co-Founder & CEO, Anima Biotech, Inc.
• Beigene Ltd.
• Eit Health E.v.
• Lifesci Advisors
• Torreya Partners Llp
• Svb Leerink
• Inkef Capital Bv
• Latham & Watkins Llp
• Novo Holdings a/s
• Pharmaventures Ltd.
• Six Swiss Exchange Ag
• Syneos Health, Llc